EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
Partnerships
Massive Bio and Mika Health partner to expand psycho-oncology and clinical trial services across US and Europe
Precision Medicine
Jun 2, 2024
This week:
Product updates
Stability AI launches Stable Diffusion 3 Medium, a text-to-image model
Foundation Models
Yesterday
Product updates
Microsoft discontinues GPT Builder in Copilot
Generative AI Applications
Yesterday
Funding
BlinqIO raises USD 5 million in funding to expand operations
Generative AI Applications
Yesterday
Product updates
Databricks launches innovations to Mosaic AI for production-quality applications
Generative AI Infrastructure
Yesterday
M&A
Rebellions and Sapeon Korea merge to challenge global AI chip leader
Generative AI Infrastructure
Yesterday
M&A
Pluxee to acquire Cobee; expands employee benefits offering
Remote Work Infrastructure
Yesterday
Product updates
Space and Time launches 'Proof of SQL' solution on GitHub
Enterprise Blockchain Solutions
Yesterday
Partnerships
Lido partners with Mellow Finance to launch liquid restaking vaults
Decentralized Finance (DeFi)
Yesterday
Funding
Rivia raises EUR 3 million in seed funding
Clinical Trial Technology
Yesterday
Product updates
Partnerships
Databricks and Shutterstock collaborate to launch enterprise-optimized ImageAI model
Generative AI Infrastructure
Yesterday
Precision Medicine

Precision Medicine

Jun 2, 2024

Massive Bio and Mika Health partner to expand psycho-oncology and clinical trial services across US and Europe

Partnerships

  • Massive Bio and Mika Health have partnered to enhance patient access to psycho-oncology services, biomarker testing, and clinical trials.

  • The partnership expects to expand patients’ access to Mika’s Digital Therapeutic for treating oncology-related fatigue, anxiety, and depression. Subsequently, patients using Digital Therapeutic can opt into Massive Bio’s clinical trial matching and biomarker testing service, while Mika’s Digital Therapy will be available to Massive Bio's cancer patient registry. By leveraging AI-powered data-driven insights, the companies aim to provide personalized psychotherapy, symptom management, side-effect interception, and educational resources to their patients.

  • Mika Health, also known as Fosanis, is a digital health company headquartered in Germany that specializes in providing AI-powered precision medicine solutions designed to support cancer patients through the treatment process. The company’s proprietary "Mika" app offers a range of services, including symptom tracking, personalized guidance, and practical advice on managing cancer-related physical and emotional challenges.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.